scispace - formally typeset
C

Claire W. Hallahan

Researcher at National Institutes of Health

Publications -  74
Citations -  13630

Claire W. Hallahan is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Cytotoxic T cell & CD8. The author has an hindex of 52, co-authored 74 publications receiving 13095 citations. Previous affiliations of Claire W. Hallahan include Schering-Plough.

Papers
More filters
Journal ArticleDOI

Wegener granulomatosis : an analysis of 158 patients

TL;DR: The course of Wegener granulomatosis has been dramatically improved by daily treatment with cyclophosphamide and glucocorticoids, and has led to increasing concerns about toxicity resulting from prolonged cycloph phosphamide therapy and has encouraged investigation of other therapeutic regimens.
Journal ArticleDOI

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

TL;DR: Results indicated that nonprogressors were differentiated by increased proliferative capacity of HIV-specific CD8+ T cells linked to enhanced effector function, and the relative absence of these functions in progressors may represent a mechanism by which HIV avoids immunological control.
Journal ArticleDOI

Persistence of HIV in Gut-Associated Lymphoid Tissue despite Long-Term Antiretroviral Therapy

TL;DR: It is suggested that the GALT may play a major role in the persistence of HIV in such individuals who had been receiving effective antiviral therapy for prolonged periods of time, and a possible mechanism for the maintenance of viral reservoirs revolving around the Galt of HIV-infected individuals despite long-term viral suppression is provided.
Journal ArticleDOI

Cyclophosphamide-Induced Cystitis and Bladder Cancer in Patients with Wegener Granulomatosis

TL;DR: The incidence, clinical manifestations, and natural history of cyclophosphamide-mediated urotoxicity in a cohort of patients with Wegener granulomatosis are described and recommendations for surveillance are discussed.